UB Paderborn / Katalog / Suche / in CDI

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A

Blood, 2016-08, Vol.128 (5), p.630-637

2016

Volltextzugriff (PDF)

Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty

Journal of the American Academy of Orthopaedic Surgeons, 2011-12, Vol.19 (12), p.768

2011

Volltextzugriff (PDF)

Hemophilia: A Review of Perioperative Management for Cardiac Surgery

Journal of cardiothoracic and vascular anesthesia, 2022-01, Vol.36 (1), p.246-257

2022

Volltextzugriff (PDF)

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

British journal of haematology, 2023-01, Vol.200 (2), p.229-239

2023

Volltextzugriff (PDF)

American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty

Journal of bone and joint surgery. American volume, 2012-04, Vol.94 (8), p.746

2012

Volltextzugriff (PDF)

Treatment with Marstacimab for People with Severe Hemophilia a or B: a Plain Language Summary of the results from a short-term study and a longer-term study

Future Rare Diseases, 2023-12, Vol.3 (4)

2023

Volltextzugriff (PDF)

Abnormalities in hemostasis in acute promyelocytic leukemia

Hematological oncology, 2002-03, Vol.20 (1), p.33-41

2002

Volltextzugriff (PDF)

Fibrinogen Replacement Underutilization in ECMO

Blood, 2020-11, Vol.136 (Supplement 1), p.4-5

2020

Volltextzugriff (PDF)

In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice

Experimental hematology, 2011-05, Vol.39 (5), p.580-590.e1

2011

Volltextzugriff (PDF)

ACQUIRED HEMOPHILIA

Reviews in clinical and experimental hematology, 2001-12, Vol.5 (4), p.389-404

2001

Volltextzugriff (PDF)

Argatroban use in heparin-induced thrombocytopenia

Expert opinion on pharmacotherapy, 2008-08, Vol.9 (11), p.1963-1967

2008

Volltextzugriff (PDF)

Long-Term Follow-up of Patients with Congenital Thrombotic Thrombocytopenia Purpura Receiving Plasma-Derived Factor VIII Containing (Koate®)

Blood, 2022-11, Vol.140 (Supplement 1), p.5644-5646

2022

Volltextzugriff (PDF)

The Clinical Spectrum of Thrombotic Thrombocytopenic Purpura

Seminars in thrombosis and hemostasis, 2005-12, Vol.31 (6), p.673-680

2005

Volltextzugriff (PDF)

Thrombotic Events with NovoSeven® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Blood, 2018-11, Vol.132 (Supplement 1), p.1203-1203

2018

Volltextzugriff (PDF)

Presentation and Management of a Stage Ia Lung Cancer Patient With a Paraneoplastic Factor VIII Inhibitor

The Annals of thoracic surgery, 2006, Vol.81 (1), p.362-364

2006

Volltextzugriff (PDF)

Clinical and laboratory phenotype variability in type 2M von Willebrand disease

Journal of thrombosis and haemostasis, 2017-08, Vol.15 (8), p.1559-1566

2017

Volltextzugriff (PDF)

Dosing Factor in Pediatric and Adult Hemophilia Patients Using Ideal Body Weight Versus actual Body Weight

Blood, 2016-12, Vol.128 (22), p.4958-4958

2016

Volltextzugriff (PDF)

Bleeding Phenotype with Various Bay 94-9027 Dosing Regimens: Subanalyses from the Protect VIII Study

Blood, 2014-12, Vol.124 (21), p.1526-1526

2014

Volltextzugriff (PDF)

Red Cell Exchange: A Concise Review of Indications and Management

Blood, 2017-12, Vol.130, p.4800-4800

2017

Volltextzugriff (PDF)

Exercise may decrease further destruction in the adult haemophilic joint

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-05, Vol.12 (3), p.237-240

2006

Volltextzugriff (PDF)

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Blood, 2016-12, Vol.128 (22), p.252-252

2016

Volltextzugriff (PDF)

The Clinical Spectrum of Thrombotic Thrombocytopenic Purpura

Seminars in thrombosis and hemostasis, 2005, Vol.31 (6), p.673-680

2005

Volltextzugriff (PDF)

Racial disparities in survival of adult T-cell leukemia/lymphoma patients in the United States: A SEER database analysis

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e16503-e16503

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A

Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty

Hemophilia: A Review of Perioperative Management for Cardiac Surgery

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty

Treatment with Marstacimab for People with Severe Hemophilia a or B: a Plain Language Summary of the results from a short-term study and a longer-term study

Abnormalities in hemostasis in acute promyelocytic leukemia

Fibrinogen Replacement Underutilization in ECMO

In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice

ACQUIRED HEMOPHILIA

Argatroban use in heparin-induced thrombocytopenia

Long-Term Follow-up of Patients with Congenital Thrombotic Thrombocytopenia Purpura Receiving Plasma-Derived Factor VIII Containing (Koate®)

The Clinical Spectrum of Thrombotic Thrombocytopenic Purpura

Thrombotic Events with NovoSeven® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Presentation and Management of a Stage Ia Lung Cancer Patient With a Paraneoplastic Factor VIII Inhibitor

Clinical and laboratory phenotype variability in type 2M von Willebrand disease

Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1

Dosing Factor in Pediatric and Adult Hemophilia Patients Using Ideal Body Weight Versus actual Body Weight

Bleeding Phenotype with Various Bay 94-9027 Dosing Regimens: Subanalyses from the Protect VIII Study

Red Cell Exchange: A Concise Review of Indications and Management

Exercise may decrease further destruction in the adult haemophilic joint

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

The Clinical Spectrum of Thrombotic Thrombocytopenic Purpura

Racial disparities in survival of adult T-cell leukemia/lymphoma patients in the United States: A SEER database analysis

Suchergebnisse filtern